/West%20Pharmaceutical%20Services%2C%20Inc_%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures and sells containment and delivery systems for injectable drugs and healthcare products. With a market cap of $24.4 billion, West Pharmaceutical’s operations span the Americas, Europe, the Middle East, Africa, and the Indo-Pacific. WST is expected to announce its fourth-quarter results on Thursday, Feb. 20.
Ahead of the event, analysts expect West Pharmaceutical to report a non-GAAP profit of $1.75 per share, down 4.4% from $1.83 per share reported in the year-ago quarter. While the company has surpassed analysts’ bottom-line estimates thrice over the past four quarters, it has missed the estimates on one other occasion. Its adjusted EPS for the last reported quarter dropped 14.4% year-over-year to $1.85 but surpassed the consensus estimates by a notable 22.5%.
